25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial

NCT02447185 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: Ranibizumab
DRUG: Triamcinolone Acetonide

Sponsor

JUNYAN ZHANG

Collaborators

[object Object]